A randomised, controlled Phase 1/2 study in healthy adults of a seasonal influenza vaccine containing an insulin-based adjuvant to evaluate safety and immunogenicity

Trial Profile

A randomised, controlled Phase 1/2 study in healthy adults of a seasonal influenza vaccine containing an insulin-based adjuvant to evaluate safety and immunogenicity

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs ADVAX; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Adverse reactions; First in man; Pharmacodynamics
  • Sponsors Vaxine
  • Most Recent Events

    • 12 Jun 2016 Results of phase I part of this study (n=98) published in the Vaccine
    • 29 Aug 2011 Status changed from active, no longer recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
    • 11 May 2009 Status changed from not stated to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top